Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-8-1
pubmed:abstractText
Obesity is increasing at an alarming rate, and its related disorders are placing a considerable strain on our healthcare system. Although they are not always coincident, obesity is often accompanied by hyperlipidemia. Both obesity and hyperlipidemia are independently associated with atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and insulin resistance (IR). Thus, we sought to determine the relative contributions of obesity and hyperlipidemia to these associated pathologies. Obese agouti (A(y)/a) mice and their littermate controls (a/a) were placed on an LDL receptor (LDLR)(-/-) background. At 4 mo of age, mice were either maintained on chow diet (CD) or placed on Western diet (WD) for 12 wk. These genetic and dietary manipulations yielded four experimental groups: 1) lean, a/a;LDLR(-/-)CD; 2) genetic-induced obesity (GIO), A(y)/a;LDLR(-/-)CD; 3) diet-induced obesity (DIO), a/a;LDLR(-/-)WD; and 4) genetic- plus diet-induced obesity (GIO/DIO), A(y)/a;LDLR(-/-)WD. Lipoprotein profiles revealed increased VLDL and LDL particles in WD-fed mice compared with CD-fed controls. The hyperlipidemia present in this mouse model was the result of both increased hepatic triglyceride production and delayed lipoprotein clearance from the plasma. Both WD-fed groups exhibited similar levels of atherosclerotic lesion area, with increased obesity in the GIO/DIO group having no impact on atherogenesis. However, the severe obesity in the GIO/DIO group did aggravate NAFLD and IR. These findings suggest that, although obesity and hyperlipidemia exert individual pathological effects, the combination of the two has the potential to exert an additive effect on NAFLD and IR but not atherosclerosis in this mouse model.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0193-1849
pubmed:author
pubmed:issnType
Print
pubmed:volume
293
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E492-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17566116-Adipose Tissue, pubmed-meshheading:17566116-Adiposity, pubmed-meshheading:17566116-Agouti Signaling Protein, pubmed-meshheading:17566116-Animals, pubmed-meshheading:17566116-Atherosclerosis, pubmed-meshheading:17566116-Diet, Atherogenic, pubmed-meshheading:17566116-Fatty Liver, pubmed-meshheading:17566116-Female, pubmed-meshheading:17566116-Insulin Resistance, pubmed-meshheading:17566116-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:17566116-Lipids, pubmed-meshheading:17566116-Lipoproteins, pubmed-meshheading:17566116-Liver, pubmed-meshheading:17566116-Male, pubmed-meshheading:17566116-Mice, pubmed-meshheading:17566116-Mice, Inbred C57BL, pubmed-meshheading:17566116-Mice, Knockout, pubmed-meshheading:17566116-Obesity, pubmed-meshheading:17566116-Receptors, LDL, pubmed-meshheading:17566116-Triglycerides
pubmed:year
2007
pubmed:articleTitle
Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
pubmed:affiliation
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural